Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2009
12/15/2009US7632498 MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
12/15/2009US7632496 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone
12/15/2009US7632495 Administering fibrinogen like protein 2 (fgl2) or a nucleic acid encoding it; preventing graft versus host rejection, autoimmune disease, and allergies; T-cell proliferation inhibitors
12/15/2009CA2439872C Leporipox-based vector vaccines
12/15/2009CA2345138C Polymer conjugates of interferon beta-1a and their uses
12/15/2009CA2344049C Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
12/15/2009CA2337965C Attenuated equine herpesvirus
12/15/2009CA2333125C Alpha emitting constructs and uses thereof
12/15/2009CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/15/2009CA2294996C Angiotensin derivatives
12/10/2009WO2009149443A2 A metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
12/10/2009WO2009149393A2 Improved cancer drug delivery using modified transferrin
12/10/2009WO2009149382A2 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
12/10/2009WO2009149370A1 Methods for the treatment of rheumatoid arthritis
12/10/2009WO2009149306A2 Complement depleting compounds and methods of treating cancer comprising monoclonal antibody therapy and said complement depleting compounds
12/10/2009WO2009149281A1 Immunotoxins and uses thereof
12/10/2009WO2009149252A1 Vaccines for prevention and treatment of addiction
12/10/2009WO2009149189A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009WO2009149185A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009WO2009148928A1 Monoclonal antibodies to basic fibroblast growth factor
12/10/2009WO2009148915A2 Methods for predicting patient response to modulation of the co-stimulatory pathway
12/10/2009WO2009148895A1 Coccidiosis vaccines
12/10/2009WO2009148627A1 Recombinant antigens for diangnosis and prevention of spotted fever rickettsiae
12/10/2009WO2009148593A1 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009WO2009148575A1 Interleukin-1 alpha abs and methods of use
12/10/2009WO2009148541A1 Pip-2 inhibition-based antiviral and anti-hyperlipidemic therapies
12/10/2009WO2009148488A2 Use of oncolytic herpes viruses for killing cancer stem cells
12/10/2009WO2009148148A1 Neuroinvasion inhibitor
12/10/2009WO2009147980A1 Use of inactivated japanese encephalitis virus particle as adjuvant
12/10/2009WO2009147781A1 Antitumor agent
12/10/2009WO2009147695A1 Anticancer agent
12/10/2009WO2009147248A2 Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
12/10/2009WO2009147201A2 Anti-inflammatory agents
12/10/2009WO2009146902A1 A vaccine for the prevention and therapy of hcv infections
12/10/2009WO2009146867A1 Pestivirus replicons providing an rna-based viral vector system
12/10/2009WO2009146523A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
12/10/2009WO2009129476A3 An antibody bound synthetic vesicle containing active agent molecules
12/10/2009WO2009128951A3 Compositions of respiratory synctial virus proteins and methods of use
12/10/2009WO2009117736A3 Avian virus vaccines and uses thereof
12/10/2009WO2009117640A3 Antibodies against interleukin-10 like cytokines and uses therefor
12/10/2009WO2009116982A3 Pre-or post-exposure treatment for filovirus or arenavirus infection
12/10/2009WO2009115509A3 Antigenic protein fragments of streptococcus pneumoniae
12/10/2009WO2009109860A3 Mutant forms of chlamydia htra
12/10/2009WO2009103105A3 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
12/10/2009WO2009082647A3 Recombinant rift valley fever (rvf) viruses and methods of use
12/10/2009WO2009064825A3 Bcg vaccine strains protecting against the establishment of latent mycobacterium tuberculosis infection
12/10/2009WO2009060086A3 Increase of immune response and targeting by antigens and/or drug linkage
12/10/2009WO2009056634A3 Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (lrp6)
12/10/2009WO2008154018A3 Properdin modulation of alternative pathway and uses thereof
12/10/2009WO2008123999A9 Anti-ige antibodies
12/10/2009WO2008109440A8 Predicting response to a her dimerisation inhibitor based on low her3 expression
12/10/2009US20090306195 Fusion Proteins of Mycobacterium Tuberculosis
12/10/2009US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
12/10/2009US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
12/10/2009US20090305418 Cell therapy method for the treatment of tumors
12/10/2009US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
12/10/2009US20090305398 Recombinant Double-Stranded RNA Phage, and Use of the Same
12/10/2009US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009US20090304805 Combinations and modes of administration of therapeutic agents and combination therapy
12/10/2009US20090304799 Nanoemulsion influenza vaccine
12/10/2009US20090304788 Encapsulated materials and methods for encapsulating materials
12/10/2009US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen
12/10/2009US20090304751 Vault compositions for immunization against chlamydia genital infection
12/10/2009US20090304750 Novel prime-boost combinations of attenuated mycobacterium
12/10/2009US20090304749 Method of Producing Rough Strains of Bacteria and Uses Thereof
12/10/2009US20090304748 Clostridial toxin pharmaceutical compositions
12/10/2009US20090304747 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
12/10/2009US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009US20090304745 Chimeric alphavirus replicon particles
12/10/2009US20090304744 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
12/10/2009US20090304743 Composition and Methods for Immunisation Using CD1D Ligands
12/10/2009US20090304742 Influenza vaccines with reduced amount of emulsion adjuvant
12/10/2009US20090304741 Yeast-Dendritic Cell Vaccines and Uses Thereof
12/10/2009US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region
12/10/2009US20090304739 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
12/10/2009US20090304738 Methods for Enhancing Immune Responses
12/10/2009US20090304737 Vaccine Against Mycoplasma PRRSV
12/10/2009US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
12/10/2009US20090304735 Immunogenic Compositions
12/10/2009US20090304734 Immunogens for meningitidis-a vaccines
12/10/2009US20090304733 Vaccine comprising recombinant ct or lt toxin
12/10/2009US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications
12/10/2009US20090304731 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
12/10/2009US20090304730 Influenza vaccine
12/10/2009US20090304729 Cell-derived viral vaccines with low levels of residual cell dna
12/10/2009US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof
12/10/2009US20090304727 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
12/10/2009US20090304726 Viral display vehicles for treating multiple sclerosis
12/10/2009US20090304725 Vaccine and Antigen Mimotopes Against Cancerous Diseases Associated with the Carcinoembryonic Antigen CEA
12/10/2009US20090304724 Compositions and Methods for Stimulating Gastrointestinal Motility
12/10/2009US20090304723 Mono-and disaccharide derivatives
12/10/2009US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/10/2009US20090304721 Toxin conjugated eph receptor antibodies
12/10/2009US20090304720 Active Agent-Loaded Nanoparticles Based On Hydrophilic Proteins
12/10/2009US20090304719 Activatable binding polypeptides and methods of identification and use thereof
12/10/2009US20090304718 Antibody Molecules Specific for Fibroblast Activation Protein and Immunoconjugates Containing Them
12/10/2009US20090304717 Immuno-RNA-Constructs
12/10/2009US20090304716 Treatment of metastatic breast cancer
12/10/2009US20090304715 Modified antibodies with enhanced biological activities
12/10/2009US20090304714 IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 1823